Anti-doping check / O-049
How to check a peptide against the WADA Prohibited List
Check the identity, class and year. Exact-name search is only the first step because unnamed analogues can be captured by class wording.
To check a peptide, identify the exact substance and aliases, open the current WADA Prohibited List, search the names, then read the relevant class and catch-all wording. Record the List year, section, match type and date. A nil exact-name search does not mean permitted.
Run the check in six steps
- 1
Identify the exact substance
Record the chemical name, label name, aliases, variants and every declared ingredient.
- 2
Open the current WADA List
Confirm the List year and effective date before searching.
- 3
Search names and synonyms
Check the exact term, common aliases and variant wording.
- 4
Read the class and catch-all wording
Inspect the surrounding section for similar structures, biological effects and unnamed analogues.
- 5
Record the match type
Use explicit, class or catch-all, uncertain, or not located, with the section and date.
- 6
Escalate uncertainty
Ask UK Anti-Doping, your anti-doping organisation or qualified sports-medicine support before use. Do not treat silence as permission.
Keep a record another person can repeat
| Field | Example of the required detail |
|---|---|
| Substance identity | Exact label term, full chemical or medicine name, aliases and variant. |
| Product composition | Every declared ingredient, plus whether the vial identity is independently established. |
| List version | 2026 Prohibited List, effective 1 January 2026. |
| Section checked | The relevant named substance, class and catch-all wording. |
| Outcome | Explicit match, class or catch-all match, uncertain, or not located. |
| Date and source | Official WADA URL and date accessed. |
Why “not found” is not clearance
UK Anti-Doping states that not every prohibited substance is specifically named and that substances with similar chemical structures or biological effects can also be prohibited. A product label can also omit an ingredient or use an alias the PDF search does not recognise.
Return to the strict-liability framework behind the check before acting on an uncertain result.
How we publish WADA status
Our compound pages show the official List year, access date, exact section and match type. We distinguish “not located” from “permitted” and record product-identity uncertainty as a separate anti-doping risk.
WADA check questions
Can I search the PDF for the peptide name only?
Start with the exact name and aliases, then inspect the relevant class and catch-all language. A missing exact name can still fall within a prohibited class or similar-substance clause.
Which WADA List should I use?
Use the current List that applies on the relevant date. The 2026 List took effect on 1 January 2026. Record the version and access date because the List changes.
Can Global DRO clear an experimental peptide?
Global DRO helps check medications. An experimental product with uncertain identity or no authorised medicine record may not be resolved by that tool. Use the WADA List and seek advice from your anti-doping organisation.
Does a laboratory certificate protect an athlete?
No. A certificate may be incomplete, unmatched or limited to attributes unrelated to anti-doping status. Strict liability still applies to prohibited substances found in the athlete's system.
Official anti-doping sources
- WADA 2026 Prohibited ListAccessed 7 August 2026
- UK Anti-Doping: the Prohibited ListAccessed 7 August 2026
- UK Anti-Doping: checking medicationsAccessed 7 August 2026
- Athletes and peptide riskAccessed 7 August 2026
- what changed on the current ListSources checked 9 August 2026
Editorial experience
From our work: how we checked this page
For topical-map item O-049, How to check a peptide against the WADA Prohibited List was checked as a distinct editorial task, not treated as a generic peptide page. We reviewed 3 unique external sources and 5 internal destinations in the page, then checked that the opening answer, headings, source descriptions and linked next steps stayed within the same claim boundary. The count records links in the published page and is not a claim that every source carries equal evidential weight.
Yianni Kiromitis checked the page against its mapped purpose, verified the cited sources, reviewed the internal routes and approved the final wording as Lead Author, Publisher and Managing Editor. This page does not carry a specialist review credit because its publication decision did not require a scientific or clinical conclusion beyond the named material it links to.
We did not use patient experience, a personal treatment outcome, seller testimony or an assumed product identity to support this page. The publication did not independently test a vial for this review. Where a page refers to a laboratory result, that result applies only to the named sample, method and attribute. We kept uncertainty beside the conclusion, recorded which source supports each material claim, and checked that the visible review date matches the publication record. A new controlled study, regulator update, corrected source, analytical report or credible safety signal can trigger reassessment through the public correction route.